Verici Dx plc (AIM:VRCI)
0.2250
+0.0150 (7.14%)
Sep 30, 2026, 5:15 PM GMT
Verici Dx Market Cap
Verici Dx has a market cap or net worth of 5.15 million as of October 9, 2026. It is the 43,678th most valuable company in the world and the 984th biggest in the United Kingdom. Its market cap has decreased by 45.59% in one year.
Market Cap
5.15M
Enterprise Value
3.92M
Revenue
2.65M
Global Rank
Country Rank
#984 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since November 3, 2020, Verici Dx's market cap has decreased from 51.74M to 5.15M, a decrease of -90.05%. That is a compound annual growth rate of -32.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 5.15M | -53.10% |
| Dec 31, 2025 | 10.97M | 16.74% |
| Dec 31, 2024 | 9.40M | -43.40% |
| Dec 29, 2023 | 16.61M | -22.00% |
| Dec 30, 2022 | 21.29M | -71.66% |
| Dec 31, 2021 | 75.13M | -9.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 187.33B |
| GSK plc | 70.66B |
| Haleon | 30.79B |
| Smith & Nephew | 8.62B |
| CRISM Therapeutics | 7.13M |
| Cizzle Biotechnology Holdings | 6.19M |
| OptiBiotix Health | 6.04M |
| Proteome Sciences | 5.93M |